NASDAQ:VTGN
VistaGen Therapeutics Inc Stock News
$4.70
+0.0300 (+0.642%)
At Close: Apr 18, 2024
Vistagen Therapeutics, Inc. (VTGN) Q1 2024 Earnings Call Transcript
05:24am, Sunday, 13'th Aug 2023
Vistagen Therapeutics, Inc. (NASDAQ:VTGN ) Q1 2024 Earnings Conference Call August 10, 2023 4:30 PM ET Company Participants Mark Flather - VP of IR Shawn Singh - CEO Josh Prince - SVP of Business Oper
Outperforming Biotech Pops on Shareholder Buzz
10:32am, Thursday, 10'th Aug 2023
Vistagen Therapeutics Inc (NASDAQ:VTGN) is continuing its recent volatility, after today's news that healthcare investment name Commodore Capital Master LP has become a top shareholder with a 19.7% st
Why Is Vistagen Therapeutics (VTGN) Stock Up 650% Today?
03:59pm, Monday, 07'th Aug 2023
Vistagen Therapeutics (NASDAQ: VTGN ) stock is surging to impressive levels today on news of some positive trial results. The pharmaceutical producer has been struggling all year, dipping into penny s
2 Biotech Stocks Staging Large Swings
02:32pm, Monday, 07'th Aug 2023
Sage Therapeutics Inc (NASDAQ:SAGE) is crumbling to record lows today, down 52.2% at $17.25 at last check, earlier hitting a low of $16.69.
VistaGen Therapeutics (VTGN Stock) Exploded 3,471% Here's Why
09:58am, Monday, 07'th Aug 2023
Are you looking for penny stocks to buy? Are you grappling with the push and pull of skeptics saying penny stocks aren't worth it or penny stocks are a scam?
Vistagen to Announce Fiscal Year 2023 Financial Results and Provide Corporate Update Conference Call on June 28, 2023
04:30pm, Tuesday, 27'th Jun 2023
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)---- $VTGN #mentalhealth--Vistagen (NASDAQ: VTGN), a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individua
Vistagen to Present at Jefferies 2023 Global Healthcare Conference
04:30pm, Tuesday, 06'th Jun 2023
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)---- $VTGN #mentalhealth--Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individua
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)---- $VTGN #mentalhealth--Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individua
What to Look For When Finding Penny Stocks to Buy, 3 Tips
06:00am, Thursday, 23'rd Mar 2023
Use these tips for finding penny stocks to buy in 2023 The post What to Look For When Finding Penny Stocks to Buy, 3 Tips appeared first on Penny Stocks to Buy, Picks, News and Information | PennySt
VistaGen Therapeutics, Inc. (VTGN) Q3 2023 Earnings Call Transcript
11:20am, Friday, 10'th Feb 2023
VistaGen Therapeutics, Inc. (NASDAQ:VTGN ) Q3 2023 Earnings Conference Call February 7, 2023 5:00 PM ET Company Participants Mark Flather - Vice President of Investor Relations Shawn Singh - Chief Exe
VistaGen Therapeutics, Inc. (VTGN) Reports Q3 Loss, Misses Revenue Estimates
07:34pm, Tuesday, 07'th Feb 2023
VistaGen Therapeutics, Inc. (VTGN) delivered earnings and revenue surprises of 16.67% and 41.94%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for th
Vistagen to Report Fiscal Year 2023 Third Quarter Financial Results on February 7, 2023
09:09am, Monday, 06'th Feb 2023
SOUTH SAN FRANCISCO, Calif.--( BUSINESS WIRE )--Vistagen (NASDAQ: VTGN), a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety
The 3 Biggest Impacts on Penny Stocks Prices
06:00am, Wednesday, 01'st Feb 2023
These factors are the main causes of penny stocks price movement The post The 3 Biggest Impacts on Penny Stocks Prices appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStock
3 Penny Stocks Under $1 To Watch This Week
02:27pm, Wednesday, 11'th Jan 2023
Penny Stocks To Watch Under $1 This Week. The post 3 Penny Stocks Under $1 To Watch This Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
BioCryst (BCRX) Down as it Discontinues Developing PNH Drug
05:10pm, Friday, 16'th Dec 2022 Zacks Investment Research
BioCryst (BCRX) down as it drops the development of BCX9930, which was being evaluated for PNH.
